The store will not work correctly when cookies are disabled.
3-(3,5-dimethoxyphenyl)-2-(8-hydroxyquinolin-2-yl)thiazolidin-4-one
ID: ALA4758588
PubChem CID: 162657278
Max Phase: Preclinical
Molecular Formula: C20H18N2O4S
Molecular Weight: 382.44
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(OC)cc(N2C(=O)CSC2c2ccc3cccc(O)c3n2)c1
Standard InChI: InChI=1S/C20H18N2O4S/c1-25-14-8-13(9-15(10-14)26-2)22-18(24)11-27-20(22)16-7-6-12-4-3-5-17(23)19(12)21-16/h3-10,20,23H,11H2,1-2H3
Standard InChI Key: BGUPICQZUCROIV-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
27.6551 -1.9852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6540 -2.8047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3620 -3.2137 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3603 -1.5763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0689 -1.9816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0696 -2.8006 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7782 -3.2076 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.4864 -2.7968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4817 -1.9747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7726 -1.5713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3639 -4.0308 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.1999 -3.1998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2885 -4.0122 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0885 -4.1790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4943 -3.4696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9451 -2.8646 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
30.6850 -4.5588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9062 -4.3077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.3013 -4.8561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.4741 -5.6557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2571 -5.9040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8586 -5.3539 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4238 -4.9242 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
30.4330 -6.7021 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.8298 -7.2534 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5233 -4.6063 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.9179 -5.1551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
3 11 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 12 1 0
8 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
13 17 1 0
14 23 2 0
21 24 1 0
24 25 1 0
19 26 1 0
26 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 382.44 | Molecular Weight (Monoisotopic): 382.0987 | AlogP: 3.74 | #Rotatable Bonds: 4 |
Polar Surface Area: 71.89 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.30 | CX Basic pKa: 3.46 | CX LogP: 2.95 | CX LogD: 2.95 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.74 | Np Likeness Score: -0.57 |
References
1. Bhat SY,Jagruthi P,Srinivas A,Arifuddin M,Qureshi IA. (2020) Synthesis and characterization of quinoline-carbaldehyde derivatives as novel inhibitors for leishmanial methionine aminopeptidase 1., 186 [PMID:31759728] [10.1016/j.ejmech.2019.111860] |